Literature DB >> 8132778

Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis.

A E Koch1, S L Kunkel, L A Harlow, D D Mazarakis, G K Haines, M D Burdick, R M Pope, R M Strieter.   

Abstract

We have shown that human macrophages (m phi s) play an important role in the elaboration of chemotactic cytokines in rheumatoid arthritis (RA) (Koch, A. E., S. L. Kunkel, J. C. Burrows, H. L. Evanoff, G. K. Haines, R. M. Pope, and R. M. Strieter. 1991. J. Immunol. 147:2187; Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Strieter. 1992. J. Clin. Invest. 90:772; Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, S. G. Elner, and R. M. Strieter. 1992. Science (Wash. DC). 258:1798). Recently, m phi inflammatory protein-1 (MIP-1 alpha), a cytokine with chemotactic activity for m phi s and neutrophils (PMNs), has been described. We have examined the production of MIP-1 alpha using sera, synovial fluid (SF), and synovial tissue (ST) from 63 arthritic patients. MIP-1 alpha was higher in RA SF (mean, 29 +/- 8 ng/ml [SE]) compared with other forms of arthritis (2.8 +/- 1.7), or osteoarthritis (0.7 +/- 0.4; P < 0.05). RA SF MIP-1 alpha was greater than that found in either RA or normal peripheral blood (PB) (P < 0.05). Anti-MIP-1 alpha neutralized 36 +/- 3% (mean +/- SE) of the chemotactic activity for m phi s, but not PMNs, found in RA SFs. RA SF and PB mononuclear cells produced antigenic MIP-1 alpha. Mononuclear cell MIP-1 alpha production was augmented with phytohemagglutinin or LPS. Isolated RA ST fibroblast production of antigenic MIP-1 alpha was augmented upon incubation of cells with LPS, and to a lesser extent with tumor necrosis factor-alpha. Isolated RA ST m phi s expressed constitutive MIP-1 alpha mRNA and antigenic MIP-1 alpha. Using ST immunohistochemistry, MIP-1 alpha+ cells from RA compared with normal were predominantly m phi s and lining cells (P < 0.05). These results suggest that MIP-1 alpha plays a role in the selective recruitment of m phi s in synovial inflammation associated with RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132778      PMCID: PMC293992          DOI: 10.1172/JCI117097

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Quantitative analysis of cytokine gene expression in rheumatoid arthritis.

Authors:  G S Firestein; J M Alvaro-Gracia; R Maki; J M Alvaro-Garcia
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

Review 2.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.

Authors:  S D Wolpe; A Cerami
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

3.  Macrophage inflammatory protein-1: unique action on the hypothalamus to evoke fever.

Authors:  F J Miñano; M Sancibrian; M Vizcaino; X Paez; G Davatelis; T Fahey; B Sherry; A Cerami; R D Myers
Journal:  Brain Res Bull       Date:  1990-06       Impact factor: 4.077

4.  Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis.

Authors:  G Husby; R C Williams
Journal:  J Autoimmun       Date:  1988-08       Impact factor: 7.094

Review 5.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

7.  Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue.

Authors:  A E Koch; P G Robinson; J A Radosevich; R M Pope
Journal:  J Clin Immunol       Date:  1990-07       Impact factor: 8.317

8.  Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.

Authors:  G J Graham; E G Wright; R Hewick; S D Wolpe; N M Wilkie; D Donaldson; S Lorimore; I B Pragnell
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

9.  Macrophage inflammatory protein-1: a prostaglandin-independent endogenous pyrogen.

Authors:  G Davatelis; S D Wolpe; B Sherry; J M Dayer; R Chicheportiche; A Cerami
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

10.  Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines.

Authors:  Y Yamamura; T Hattori; K Obaru; K Sakai; N Asou; K Takatsuki; Y Ohmoto; H Nomiyama; K Shimada
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

View more
  84 in total

1.  The CC chemokine MIP-1alpha induces a selective monocyte infiltration following intradermal injection into nonhuman primates.

Authors:  P J Didier; T J Paradis; R P Gladue
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

2.  Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases.

Authors:  H Brühl; K Wagner; H Kellner; M Schattenkirchner; D Schlöndorff; M Mack
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis.

Authors:  Y Hatano; T Kasama; H Iwabuchi; R Hanaoka; H T Takeuchi; L Jing; Y Mori; K Kobayashi; M Negishi; H Ide; M Adachi
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

Review 4.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

5.  Elevated levels of beta-chemokines in bronchoalveolar lavage fluid (BALF) of individuals infected with human T lymphotropic virus type-1 (HTLV-1).

Authors:  M Seki; J I Kadota; Y Higashiyama; K Iida; T Iwashita; E Sasaki; S Maesaki; K Tomono; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

6.  Suppression of Tie-1 in endothelial cells in vitro induces a change in the genome-wide expression profile reflecting an inflammatory function.

Authors:  Barden Chan; Vikas P Sukhatme
Journal:  FEBS Lett       Date:  2009-02-21       Impact factor: 4.124

7.  Phase I evaluation of the safety, pharmacokinetics and pharmacodynamics of CP-481,715.

Authors:  Alan T Clucas; Ajit Shah; Yuanchao Derek Zhang; Vincent F Chow; Ronald P Gladue
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 8.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

9.  The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial.

Authors:  Peter W Hunt; Nancy S Shulman; Timothy L Hayes; Viktor Dahl; Ma Somsouk; Nicholas T Funderburg; Bridget McLaughlin; Alan L Landay; Oluwatoyin Adeyemi; Lee E Gilman; Brian Clagett; Benigno Rodriguez; Jeffrey N Martin; Timothy W Schacker; Barbara L Shacklett; Sarah Palmer; Michael M Lederman; Steven G Deeks
Journal:  Blood       Date:  2013-04-15       Impact factor: 22.113

10.  Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors.

Authors:  T R D J Radstake; R van der Voort; M ten Brummelhuis; M de Waal Malefijt; M Looman; C G Figdor; W B van den Berg; P Barrera; G J Adema
Journal:  Ann Rheum Dis       Date:  2004-08-26       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.